Article Text

Download PDFPDF

Correction: A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

Statistics from Altmetric.com

Rammensee H, Wiesmüller K, Chandran PA, et al. A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer. J Immuno Ther Cancer 2019;7:307. doi: 10.1186/s40425-019-0796-5.

In the article titled ‘A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer’, the author name Yamel Cardona Gloria is abbreviated incorrectly. The author’s first name is Yamel and the family name is Cardona Gloria. The correct abbreviation is Cardona Gloria Y.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.